Wilson Sonsini Goodrich & Rosati represented Asari AI in the transaction. Asari AI announced that it has launched and raised an initial funding round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Modal on the transaction. Modal, a leading skills development platform for data and analytics professionals, announced the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RapidSOS on the transaction. RapidSOS announced it raised $75 million raise led by funds and accounts managed by BlackRock, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in connection with the transaction. GDS Holdings Limited (the “Company” or “GDSH”) (NASDAQ: GDS; HKEX: 9698), a leading...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented UpLift in the transaction. UpLift, a technology-driven behavioral health company delivering in-network therapy and psychiatry, announced that it has acquired...
You must be a Standard 1 Year member to access this content.
Cooley, Travers Thorp Alberga and Jun He Law Offices advised ProfoundBio and Wilson Sonsini Goodrich and Rosati advised ProfoundBio on patent matters related to the transaction,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Orbillion in the transaction. Cultivated meat start-up Orbillion announced it has raised fresh capital that brings its cumulative funding to $15...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is advising ARCA biopharma, Inc. on the transaction, while Gibson, Dunn & Crutcher is advising Oruka Therapeutics and Cooley is advising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Tempo Therapeutics in the transaction. Tempo Therapeutics, Inc. (“Tempo”) announced the completion of a $12 million Series A equity financing round, led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lumino Labs in the transaction. Lumino Labs, an AI infrastructure start-up, announced that it has raised a $2.8 million pre-Seed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich and Rosati advised Big Sur AI on the transaction. Big Sur AI, an AI platform for e-commerce, announced a $6.9 million seed round...
You must be a Standard 1 Year member to access this content.
